Skip to content

Clinical trials

Completed Phase 2 Lymphoma, Follicular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Follicular Phase: Phase 2 Status: Completed Clear all

289 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200021
20019
20027
20036
200419
200516
200613
200721
200817
20098
201014
201111
20122
20139
20146
20156
20166
201711
20187
20193
20208
20214
20223
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed289

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center29
National Cancer Institute (NCI)16
Memorial Sloan Kettering Cancer Center15
Alliance for Clinical Trials in Oncology12
Case Comprehensive Cancer Center10
M.D. Anderson Cancer Center9
Masonic Cancer Center, University of Minnesota7
University of Nebraska7
Jonsson Comprehensive Cancer Center6
Mayo Clinic6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Follicular289
Lymphoma149
Leukemia, Lymphocytic, Chronic, B-Cell147
Lymphoma, B-Cell, Marginal Zone145
Lymphoma, Non-Hodgkin142
Lymphoma, Large B-Cell, Diffuse141
Lymphoma, Mantle-Cell137
Burkitt Lymphoma113
Lymphoma, Large-Cell, Immunoblastic109
Precursor Cell Lymphoblastic Leukemia-Lymphoma102

Trials

Showing 1 to 25 of 289. Each trial links to its page on Pharma Observatory.

189 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.